GM-CSF Production by Glioblastoma Cells Has a Functional Role in Eosinophil Survival, Activation, and Growth Factor Production for Enhanced Tumor Cell Proliferation
- 1 August 2011
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 187 (3), 1254-1263
- https://doi.org/10.4049/jimmunol.1001965
Abstract
Medicinal interventions of limited efficacy are currently available for the treatment of glioblastoma multiforme (GBM), the most common and lethal primary brain tumor in adults. The eosinophil is a pivotal immune cell in the pathobiology of atopic disease that is also found to accumulate in certain tumor tissues. Inverse associations between atopy and GBM risk suggest that the eosinophil may play a functional role in certain tumor immune responses. To assess the potential interactions between eosinophils and GBM, we cultured human primary blood eosinophils with two separate human GBM-derived cell lines (A172, U87-MG) or conditioned media generated in the presence or absence of TNF-α. Results demonstrated differential eosinophil adhesion and increased survival in response to coculture with GBM cell lines. Eosinophil responses to GBM cell line-conditioned media included increased survival, activation, CD11b expression, and S100A9 release. Addition of GM-CSF neutralizing Abs to GBM cell cultures or conditioned media reduced eosinophil adhesion, survival, and activation, linking tumor cell-derived GM-CSF to the functions of eosinophils in the tumor microenvironment. Dexamethasone, which has been reported to inhibit eosinophil recruitment and shrink GBM lesions on contrast-enhanced scans, reduced the production of tumor cell-derived GM-CSF. Furthermore, culture of GBM cells in eosinophil-conditioned media increased tumor cell viability, and generation of eosinophil-conditioned media in the presence of GM-CSF enhanced the effect. These data support the idea of a paracrine loop between GM-CSF–producing tumors and eosinophil-derived growth factors in tumor promotion/progression.Keywords
This publication has 75 references indexed in Scilit:
- Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100BInternational Immunology, 2011
- Human Airway Eosinophils Respond to Chemoattractants with Greater Eosinophil-Derived Neurotoxin Release, Adherence to Fibronectin, and Activation of the Ras–ERK Pathway When Compared with Blood EosinophilsThe Journal of Immunology, 2010
- Human Eosinophils Recognize Endogenous Danger Signal Crystalline Uric Acid and Produce Proinflammatory Cytokines Mediated by Autocrine ATPThe Journal of Immunology, 2010
- The molecular mechanism of dexamethasone-mediated effect on the blood–brain tumor barrier permeability in a rat brain tumor modelNeuroscience Letters, 2009
- AllergoOncology: the role of IgE‐mediated allergy in cancerAllergy, 2008
- Cancer-related inflammationNature, 2008
- Eosinophils in the pathogenesis of allergic airways diseaseCellular and Molecular Life Sciences, 2007
- S100A9 mediates neutrophil adhesion to fibronectin through activation of β2 integrinsBiochemical and Biophysical Research Communications, 2007
- Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host responseJournal of Leukocyte Biology, 2006
- Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell InteractionsCell Cycle, 2006